Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 49 | 2026 | 231 | 8.700 |
Why?
|
| Schizophrenia | 52 | 2026 | 532 | 7.210 |
Why?
|
| Bipolar Disorder | 31 | 2026 | 405 | 4.920 |
Why?
|
| Brain | 31 | 2026 | 2482 | 2.070 |
Why?
|
| Antipsychotic Agents | 7 | 2024 | 151 | 1.760 |
Why?
|
| Magnetic Resonance Imaging | 42 | 2026 | 3639 | 1.250 |
Why?
|
| Cognitive Dysfunction | 7 | 2025 | 192 | 1.130 |
Why?
|
| Schizophrenic Psychology | 10 | 2025 | 141 | 1.060 |
Why?
|
| Facial Recognition | 3 | 2021 | 17 | 0.950 |
Why?
|
| Prefrontal Cortex | 7 | 2020 | 150 | 0.940 |
Why?
|
| Nerve Net | 9 | 2025 | 407 | 0.940 |
Why?
|
| Auditory Cortex | 4 | 2020 | 67 | 0.900 |
Why?
|
| Cognition Disorders | 5 | 2022 | 244 | 0.890 |
Why?
|
| Cognition | 14 | 2025 | 635 | 0.860 |
Why?
|
| Electroencephalography | 15 | 2025 | 824 | 0.790 |
Why?
|
| Saccades | 10 | 2025 | 75 | 0.780 |
Why?
|
| Hallucinations | 6 | 2024 | 31 | 0.770 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 7 | 2022 | 286 | 0.720 |
Why?
|
| Psychomotor Performance | 7 | 2022 | 505 | 0.710 |
Why?
|
| Emotions | 10 | 2023 | 377 | 0.670 |
Why?
|
| Brain Mapping | 17 | 2023 | 594 | 0.640 |
Why?
|
| Young Adult | 34 | 2026 | 7025 | 0.630 |
Why?
|
| Adult | 60 | 2026 | 28721 | 0.610 |
Why?
|
| Evoked Potentials | 7 | 2025 | 202 | 0.600 |
Why?
|
| Methamphetamine | 4 | 2025 | 104 | 0.590 |
Why?
|
| Humans | 95 | 2026 | 96105 | 0.590 |
Why?
|
| Neural Pathways | 9 | 2024 | 333 | 0.590 |
Why?
|
| Evoked Potentials, Auditory | 5 | 2022 | 39 | 0.580 |
Why?
|
| Visual Perception | 4 | 2014 | 339 | 0.570 |
Why?
|
| Attention | 4 | 2019 | 413 | 0.570 |
Why?
|
| Child Behavior | 1 | 2018 | 47 | 0.560 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 32 | 0.560 |
Why?
|
| Male | 64 | 2026 | 45863 | 0.550 |
Why?
|
| Central Nervous System Stimulants | 4 | 2025 | 235 | 0.540 |
Why?
|
| Neuropsychological Tests | 14 | 2025 | 549 | 0.530 |
Why?
|
| Amygdala | 6 | 2021 | 87 | 0.520 |
Why?
|
| Feeding and Eating Disorders | 1 | 2018 | 186 | 0.490 |
Why?
|
| Female | 60 | 2026 | 50028 | 0.480 |
Why?
|
| Feeding Behavior | 1 | 2018 | 338 | 0.470 |
Why?
|
| Caudate Nucleus | 2 | 2019 | 16 | 0.470 |
Why?
|
| Aggression | 4 | 2022 | 330 | 0.470 |
Why?
|
| Alcoholism | 3 | 2023 | 191 | 0.440 |
Why?
|
| Learning | 2 | 2014 | 305 | 0.430 |
Why?
|
| Cholinergic Antagonists | 3 | 2025 | 30 | 0.400 |
Why?
|
| Parietal Lobe | 6 | 2023 | 118 | 0.370 |
Why?
|
| Motor Activity | 1 | 2014 | 332 | 0.360 |
Why?
|
| Oxytocin | 3 | 2018 | 75 | 0.350 |
Why?
|
| Connectome | 3 | 2025 | 88 | 0.350 |
Why?
|
| Reward | 3 | 2025 | 209 | 0.350 |
Why?
|
| Gray Matter | 3 | 2025 | 43 | 0.340 |
Why?
|
| Phenotype | 9 | 2025 | 2578 | 0.340 |
Why?
|
| Psychiatric Status Rating Scales | 8 | 2017 | 504 | 0.330 |
Why?
|
| Reaction Time | 4 | 2012 | 323 | 0.330 |
Why?
|
| Eye Movements | 5 | 2017 | 119 | 0.330 |
Why?
|
| Cues | 2 | 2025 | 189 | 0.330 |
Why?
|
| White Matter | 2 | 2025 | 96 | 0.320 |
Why?
|
| Pattern Recognition, Visual | 3 | 2021 | 162 | 0.320 |
Why?
|
| Social Perception | 5 | 2022 | 94 | 0.320 |
Why?
|
| Middle Aged | 32 | 2026 | 28368 | 0.310 |
Why?
|
| Frontal Lobe | 4 | 2018 | 131 | 0.310 |
Why?
|
| Adolescent | 19 | 2026 | 9895 | 0.300 |
Why?
|
| Auditory Pathways | 3 | 2021 | 35 | 0.260 |
Why?
|
| Affective Disorders, Psychotic | 2 | 2019 | 16 | 0.260 |
Why?
|
| Yohimbine | 1 | 2006 | 7 | 0.260 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2006 | 9 | 0.260 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 31 | 0.260 |
Why?
|
| Oculomotor Nerve | 1 | 2006 | 7 | 0.250 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 1765 | 0.250 |
Why?
|
| Norepinephrine | 1 | 2006 | 174 | 0.240 |
Why?
|
| Multifactorial Inheritance | 2 | 2025 | 202 | 0.240 |
Why?
|
| Arginine Vasopressin | 2 | 2017 | 44 | 0.230 |
Why?
|
| Speech | 2 | 2018 | 91 | 0.230 |
Why?
|
| Executive Function | 2 | 2018 | 106 | 0.230 |
Why?
|
| Severity of Illness Index | 4 | 2025 | 1979 | 0.230 |
Why?
|
| Personality | 2 | 2025 | 140 | 0.230 |
Why?
|
| Sex Characteristics | 2 | 2018 | 339 | 0.230 |
Why?
|
| Gyrus Cinguli | 3 | 2019 | 49 | 0.230 |
Why?
|
| Cerebellum | 2 | 2024 | 253 | 0.220 |
Why?
|
| Euphoria | 1 | 2025 | 47 | 0.220 |
Why?
|
| Marijuana Use | 1 | 2025 | 12 | 0.220 |
Why?
|
| Hyponatremia | 3 | 2010 | 30 | 0.220 |
Why?
|
| Facial Expression | 3 | 2021 | 57 | 0.220 |
Why?
|
| Photic Stimulation | 5 | 2019 | 514 | 0.210 |
Why?
|
| Pons | 1 | 2024 | 26 | 0.210 |
Why?
|
| Hippocampus | 4 | 2023 | 459 | 0.200 |
Why?
|
| Self Report | 3 | 2020 | 328 | 0.200 |
Why?
|
| Anger | 3 | 2021 | 81 | 0.190 |
Why?
|
| Cannabis | 1 | 2023 | 40 | 0.190 |
Why?
|
| Lissencephaly | 1 | 2022 | 24 | 0.190 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 32 | 0.180 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 61 | 0.170 |
Why?
|
| Mental Disorders | 3 | 2017 | 463 | 0.170 |
Why?
|
| Ventral Striatum | 1 | 2020 | 6 | 0.170 |
Why?
|
| Hostility | 1 | 2021 | 25 | 0.170 |
Why?
|
| Aging | 1 | 2026 | 766 | 0.170 |
Why?
|
| Neuroimaging | 2 | 2019 | 135 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2024 | 2494 | 0.160 |
Why?
|
| Alcohol Drinking | 1 | 2023 | 287 | 0.160 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 87 | 0.160 |
Why?
|
| Pleasure | 1 | 2019 | 14 | 0.160 |
Why?
|
| Lateral Ventricles | 1 | 2019 | 12 | 0.160 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2019 | 16 | 0.160 |
Why?
|
| Family | 5 | 2025 | 332 | 0.160 |
Why?
|
| Biomarkers | 5 | 2025 | 1930 | 0.150 |
Why?
|
| Space Perception | 2 | 2014 | 120 | 0.150 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 2019 | 27 | 0.150 |
Why?
|
| Affective Symptoms | 1 | 2019 | 56 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2534 | 0.150 |
Why?
|
| Thalamus | 2 | 2018 | 135 | 0.150 |
Why?
|
| Neostriatum | 1 | 2019 | 25 | 0.150 |
Why?
|
| Gamma Rhythm | 1 | 2019 | 16 | 0.150 |
Why?
|
| Beta Rhythm | 1 | 2019 | 19 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2020 | 938 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 120 | 0.150 |
Why?
|
| Language | 1 | 2020 | 162 | 0.150 |
Why?
|
| Neurophysins | 1 | 2018 | 4 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 2474 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 113 | 0.140 |
Why?
|
| Vasopressins | 1 | 2018 | 50 | 0.140 |
Why?
|
| Food | 1 | 2018 | 93 | 0.140 |
Why?
|
| Child | 5 | 2023 | 7625 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2018 | 138 | 0.140 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2018 | 29 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2025 | 2480 | 0.140 |
Why?
|
| Twins | 1 | 2017 | 65 | 0.130 |
Why?
|
| Visual Cortex | 2 | 2019 | 265 | 0.130 |
Why?
|
| Endophenotypes | 3 | 2022 | 19 | 0.130 |
Why?
|
| Functional Laterality | 2 | 2009 | 208 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 1876 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 394 | 0.130 |
Why?
|
| Perforant Pathway | 1 | 2016 | 6 | 0.120 |
Why?
|
| Emotional Intelligence | 1 | 2016 | 22 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2018 | 1319 | 0.120 |
Why?
|
| Citalopram | 1 | 2015 | 21 | 0.120 |
Why?
|
| HIV Infections | 1 | 2025 | 974 | 0.120 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2026 | 224 | 0.110 |
Why?
|
| Genotype | 4 | 2020 | 1881 | 0.110 |
Why?
|
| Healthy Volunteers | 3 | 2021 | 157 | 0.110 |
Why?
|
| Delusions | 1 | 2014 | 12 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2025 | 76 | 0.110 |
Why?
|
| Social Behavior | 1 | 2016 | 309 | 0.100 |
Why?
|
| Third Ventricle | 2 | 2010 | 14 | 0.100 |
Why?
|
| Thirst | 2 | 2010 | 19 | 0.100 |
Why?
|
| Internal Capsule | 1 | 2012 | 9 | 0.090 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2012 | 3 | 0.090 |
Why?
|
| Visual Fields | 2 | 2010 | 100 | 0.090 |
Why?
|
| Risk Factors | 4 | 2025 | 5961 | 0.090 |
Why?
|
| Behavior Control | 2 | 2023 | 4 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2025 | 1791 | 0.090 |
Why?
|
| Brain Waves | 1 | 2012 | 36 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2012 | 226 | 0.090 |
Why?
|
| Polyuria | 1 | 2010 | 7 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2017 | 1423 | 0.080 |
Why?
|
| Motion Perception | 1 | 2011 | 107 | 0.080 |
Why?
|
| Research Design | 1 | 2014 | 631 | 0.080 |
Why?
|
| Auditory Perception | 3 | 2019 | 105 | 0.080 |
Why?
|
| Models, Psychological | 2 | 2025 | 166 | 0.080 |
Why?
|
| Electric Injuries | 1 | 2009 | 21 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 3927 | 0.080 |
Why?
|
| Ethanol | 2 | 2023 | 270 | 0.080 |
Why?
|
| Anisotropy | 3 | 2016 | 65 | 0.080 |
Why?
|
| Intelligence | 1 | 2009 | 73 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2008 | 71 | 0.070 |
Why?
|
| Memory | 2 | 2009 | 229 | 0.070 |
Why?
|
| Rest | 2 | 2018 | 53 | 0.070 |
Why?
|
| Water Intoxication | 1 | 2007 | 3 | 0.060 |
Why?
|
| Acoustic Stimulation | 2 | 2021 | 131 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 1063 | 0.060 |
Why?
|
| Memory Disorders | 2 | 2021 | 72 | 0.060 |
Why?
|
| Atrophy | 1 | 2007 | 131 | 0.060 |
Why?
|
| Geniculate Bodies | 1 | 2006 | 141 | 0.060 |
Why?
|
| Fixation, Ocular | 1 | 2006 | 50 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1957 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2006 | 205 | 0.060 |
Why?
|
| Interview, Psychological | 2 | 2017 | 69 | 0.060 |
Why?
|
| Personality Inventory | 1 | 2025 | 112 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 233 | 0.060 |
Why?
|
| Temporal Lobe | 2 | 2019 | 195 | 0.060 |
Why?
|
| Social Class | 1 | 2025 | 145 | 0.060 |
Why?
|
| Somatosensory Cortex | 1 | 2007 | 168 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2024 | 50 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2025 | 599 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1267 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2025 | 713 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1619 | 0.050 |
Why?
|
| Thinking | 1 | 2023 | 39 | 0.050 |
Why?
|
| Speech Perception | 2 | 2014 | 74 | 0.050 |
Why?
|
| Individuality | 1 | 2023 | 114 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1973 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 48 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2025 | 334 | 0.050 |
Why?
|
| Psychological Techniques | 1 | 2021 | 3 | 0.040 |
Why?
|
| Biology | 1 | 2022 | 52 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2022 | 82 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 9175 | 0.040 |
Why?
|
| Sexual and Gender Minorities | 1 | 2025 | 250 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 451 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2022 | 393 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2021 | 86 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 208 | 0.040 |
Why?
|
| Corpus Striatum | 2 | 2012 | 92 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 4155 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2020 | 68 | 0.040 |
Why?
|
| Acoustics | 1 | 2019 | 51 | 0.040 |
Why?
|
| Reflex, Startle | 1 | 2019 | 32 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 128 | 0.040 |
Why?
|
| Putamen | 1 | 2019 | 14 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 90 | 0.040 |
Why?
|
| Functional Neuroimaging | 1 | 2019 | 32 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 2880 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 769 | 0.040 |
Why?
|
| Genomics | 1 | 2024 | 857 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 244 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1176 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2020 | 703 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 615 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 121 | 0.030 |
Why?
|
| Nasal Provocation Tests | 1 | 2017 | 129 | 0.030 |
Why?
|
| Happiness | 1 | 2016 | 12 | 0.030 |
Why?
|
| Animals | 3 | 2020 | 28891 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Borderline Personality Disorder | 1 | 2016 | 36 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 311 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 518 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 1805 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 438 | 0.030 |
Why?
|
| Chlorpromazine | 1 | 2014 | 14 | 0.030 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2014 | 22 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 118 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 926 | 0.030 |
Why?
|
| Hearing | 1 | 2014 | 64 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 20968 | 0.020 |
Why?
|
| Research | 1 | 2014 | 265 | 0.020 |
Why?
|
| Psychometrics | 1 | 2014 | 340 | 0.020 |
Why?
|
| Affect | 1 | 2015 | 397 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 4671 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 66 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 908 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 137 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 630 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 168 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 344 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 668 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2010 | 37 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 4374 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 3110 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 236 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 52 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2010 | 90 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 379 | 0.020 |
Why?
|
| Ocular Motility Disorders | 1 | 2009 | 16 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2009 | 30 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 298 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 92 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2009 | 65 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 312 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 171 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2860 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2009 | 215 | 0.020 |
Why?
|
| Drinking | 1 | 2007 | 35 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2007 | 80 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2008 | 178 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 5580 | 0.010 |
Why?
|
| United States | 1 | 2014 | 7768 | 0.010 |
Why?
|